Cargando…

Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats’ disease

PURPOSE: To report a case of adult-onset Coats’ disease that had worsening of macular edema and progressive macular traction following cryotherapy and repeated intravitreal bevacizumab injections due to formation of a secondary epiretinal membrane which only improved following pars plana vitrectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Elnahry, Ayman G., Sallam, Essam M., Guirguis, Kirollos J., Talbet, Joseph H., Abdel-Kader, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624194/
https://www.ncbi.nlm.nih.gov/pubmed/31334386
http://dx.doi.org/10.1016/j.ajoc.2019.100508
_version_ 1783434219438997504
author Elnahry, Ayman G.
Sallam, Essam M.
Guirguis, Kirollos J.
Talbet, Joseph H.
Abdel-Kader, Ahmed A.
author_facet Elnahry, Ayman G.
Sallam, Essam M.
Guirguis, Kirollos J.
Talbet, Joseph H.
Abdel-Kader, Ahmed A.
author_sort Elnahry, Ayman G.
collection PubMed
description PURPOSE: To report a case of adult-onset Coats’ disease that had worsening of macular edema and progressive macular traction following cryotherapy and repeated intravitreal bevacizumab injections due to formation of a secondary epiretinal membrane which only improved following pars plana vitrectomy and membrane peeling. OBSERVATIONS: A 35-year-old male presented with diminution of vision in his left eye and was found to have localized telangiectatic retinal vessels and aneurysmal dilatations with massive exudation and cystoid macular edema. He was diagnosed as adult-onset Coats’ disease and treated with cryotherapy and a concomitant intravitreal injection of 2.5 mg bevacizumab followed by 3 monthly intravitreal injections of 2.5 mg bevacizumab and a single injection of 4 mg triamcinolone acetonide. Partial obliteration of the telangiectatic vessels and aneurysmal dilatations with improvement in surrounding lipid and fluid exudate was achieved, however, this was associated with progressive worsening of macular edema and macular traction due to formation of an epiretinal membrane which only improved following vitrectomy and membrane peeling. Effect of therapy at each stage was evaluated using visual acuity testing, fundus examination, fundus fluorescein angiography, and optical coherence tomography. CONCLUSION AND IMPORTANCE: A secondary epiretinal membrane can develop following treatment of adult-onset Coats’ disease and cause traction especially when combining cryotherapy with bevacizumab injections. Vitrectomy in such cases with membrane peeling may result in improvement of anatomical and functional outcomes.
format Online
Article
Text
id pubmed-6624194
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-66241942019-07-22 Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats’ disease Elnahry, Ayman G. Sallam, Essam M. Guirguis, Kirollos J. Talbet, Joseph H. Abdel-Kader, Ahmed A. Am J Ophthalmol Case Rep Case Report PURPOSE: To report a case of adult-onset Coats’ disease that had worsening of macular edema and progressive macular traction following cryotherapy and repeated intravitreal bevacizumab injections due to formation of a secondary epiretinal membrane which only improved following pars plana vitrectomy and membrane peeling. OBSERVATIONS: A 35-year-old male presented with diminution of vision in his left eye and was found to have localized telangiectatic retinal vessels and aneurysmal dilatations with massive exudation and cystoid macular edema. He was diagnosed as adult-onset Coats’ disease and treated with cryotherapy and a concomitant intravitreal injection of 2.5 mg bevacizumab followed by 3 monthly intravitreal injections of 2.5 mg bevacizumab and a single injection of 4 mg triamcinolone acetonide. Partial obliteration of the telangiectatic vessels and aneurysmal dilatations with improvement in surrounding lipid and fluid exudate was achieved, however, this was associated with progressive worsening of macular edema and macular traction due to formation of an epiretinal membrane which only improved following vitrectomy and membrane peeling. Effect of therapy at each stage was evaluated using visual acuity testing, fundus examination, fundus fluorescein angiography, and optical coherence tomography. CONCLUSION AND IMPORTANCE: A secondary epiretinal membrane can develop following treatment of adult-onset Coats’ disease and cause traction especially when combining cryotherapy with bevacizumab injections. Vitrectomy in such cases with membrane peeling may result in improvement of anatomical and functional outcomes. Elsevier 2019-07-09 /pmc/articles/PMC6624194/ /pubmed/31334386 http://dx.doi.org/10.1016/j.ajoc.2019.100508 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Elnahry, Ayman G.
Sallam, Essam M.
Guirguis, Kirollos J.
Talbet, Joseph H.
Abdel-Kader, Ahmed A.
Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats’ disease
title Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats’ disease
title_full Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats’ disease
title_fullStr Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats’ disease
title_full_unstemmed Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats’ disease
title_short Vitrectomy for a secondary epiretinal membrane following treatment of adult-onset Coats’ disease
title_sort vitrectomy for a secondary epiretinal membrane following treatment of adult-onset coats’ disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624194/
https://www.ncbi.nlm.nih.gov/pubmed/31334386
http://dx.doi.org/10.1016/j.ajoc.2019.100508
work_keys_str_mv AT elnahryaymang vitrectomyforasecondaryepiretinalmembranefollowingtreatmentofadultonsetcoatsdisease
AT sallamessamm vitrectomyforasecondaryepiretinalmembranefollowingtreatmentofadultonsetcoatsdisease
AT guirguiskirollosj vitrectomyforasecondaryepiretinalmembranefollowingtreatmentofadultonsetcoatsdisease
AT talbetjosephh vitrectomyforasecondaryepiretinalmembranefollowingtreatmentofadultonsetcoatsdisease
AT abdelkaderahmeda vitrectomyforasecondaryepiretinalmembranefollowingtreatmentofadultonsetcoatsdisease